erlotinib
Selected indexed studies
- Erlotinib-induced dry eye. (Indian J Ophthalmol, 2023) [PMID:37026321]
- Erlotinib hydrochloride. (Nat Rev Drug Discov, 2005) [PMID:15962526]
- Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD. (Front Immunol, 2024) [PMID:39434878]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Erlotinib-induced dry eye. (2023) pubmed
- Erlotinib hydrochloride. (2005) pubmed
- Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD. (2024) pubmed
- Erlotinib. (2005) pubmed
- Erlotinib for the treatment of brain metastases in non-small cell lung cancer. (2016) pubmed
- Afatinib and Erlotinib in the treatment of squamous-cell lung cancer. (2018) pubmed
- Erlotinib-associated interstitial pneumonitis with successful readministration. (2024) pubmed
- Xijiao Dihuang decoction relieves the erlotinib-induced dermatitis. (2023) pubmed
- PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway. (2024) pubmed
- Erlotinib-induced leukoencephalopathy mimicking CO intoxication. (2022) pubmed